Focus Stocks
Trading Idea - Is JP Morgan close to Resistance?
Published on Wednesday, 08 February 2012 06:24 Written by TradersHuddle Wire
New York, February 8th (TradersHuddle.com) - Shares of JP Morgan Chase & Co. (NYSE:JPM) are trading very close to calculated resistance at $38.50 with the current price action closing at just $37.87 placing the stock near levels that make it difficult to buy.
JPMorgan Chase & Co. (NYSE:JPM) provides global financial services and retail banking. The Company provides services such as investment banking, securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals. JP Morgan, the second largest U.S. lender, was founded in 1823 and is headquartered in New York, NY.
JP Morgan's current stock range is defined by current calculated support defined at $34.50 and by the resistance level at $38.50, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for JP Morgan, as the stock is well above support, however, as the stock pulls back towards $34.50 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $38.50 then traders will get an opportunity to enter JP Morgan stock by establishing a position as the stock moves to a higher range.
Related Articles
- InCharge Receives $148,750 Grant From Chase To Provide Financial Education and Counseling
- Hagens Berman Investigates Facebook Underwriter Revenue Selective Disclosure Ahead of IPO, Notifies Investors of Class Action
- Joseph A. Walker Rejoins J.P. Morgan as Vice Chairman of Investment Banking
- JPMorgan Chase & Co. Declares Quarterly Coupon on Alerian MLP Index ETN
- XLF, You’ve Seen Better Days
- Stocks End Flat on Greek Woes
- TradersHuddle Dow's Update, In focus:JPM, BAC, HD, HPQ, BA
- Stocks Snapped Losing Streak
- Worst Performing Dow Component: JP Morgan
- Chase Lends, Extends Small Business Lead
Related Partner Headlines
- Wells Fargo Consensus Headed Lower - TheStreet.com
- Leadership Problem No. 1: Too Proud to Think You Might be Wrong - TheStreet.com
- Urban Outfitters, JPMorgan: S&P Gainers - TheStreet.com
- Reincarnation on Wall Street: Screw-Ups Never Die - TheStreet.com
- Jamie Dimon's Sudden Shift on Regulation: Opinion - TheStreet.com
- JPMorgan Trading Loss Focus of CFTC Investigation - TheStreet.com
- The Great Credit Crunch Continues - TheStreet.com
- Dow Today: JPMorgan Chase (JPM) Leads The Day Higher, Microsoft Corporation (MSFT) Lags - TheStreet.com
- JPMorgan 'Compelling' Despite Lower Price Target: UBS - TheStreet.com
- Lowe's, JPMorgan: S&P Laggards - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









